Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
- Sprache
-
Englisch
- Identifier
-
1209357402
Beteiligte Personen und Organisationen
Kvasnicka, Hans-Michael
Thiele, Jürgen
Bueso-Ramos, Carlos E.
Sun, William
Cortes, Jorge
Kantarjian, Hagop
Verstovsek, Srdan
Thiele, Jürgen
Bueso-Ramos, Carlos E.
Sun, William
Cortes, Jorge
Kantarjian, Hagop
Verstovsek, Srdan
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Beteiligte
- Kvasnicka, Hans-Michael
- Thiele, Jürgen
- Bueso-Ramos, Carlos E.
- Sun, William
- Cortes, Jorge
- Kantarjian, Hagop
- Verstovsek, Srdan
Ähnliche Objekte (12)
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms : document summary and in-depth discussion
A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies
Epstein-Barr virus–specific cytokine-induced killer cells for treatment of Epstein-Barr virus–related malignant lymphoma
Vemurafenib in Langerhans cell histiocytosis : report of a pediatric patient and review of the literature
Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors
Histologische, histomorphometrische und klinische Vergleichsanalyse eines synthetischen und eines xenogenen Knochenersatzmaterials zur Sinusbodenaugmentation bei ehemaligen Tumorpatienten
Influence of metasomatism on vanadium-based redox proxies for mantle peridotite
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
Myeloproliferative disorders : current perspectives on diagnostic criteria, histopathology and treatment in essential thrombocythemia, polycythemia rubra vera and chronic idiopathic myelofibrosis
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option
Differentialdiagnostik der frühen primären Myelofibrose (präPMF) gemäß der neuen WHO-Klassifikation
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms : document summary and in-depth discussion
A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies
Epstein-Barr virus–specific cytokine-induced killer cells for treatment of Epstein-Barr virus–related malignant lymphoma
Vemurafenib in Langerhans cell histiocytosis : report of a pediatric patient and review of the literature
Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors
Histologische, histomorphometrische und klinische Vergleichsanalyse eines synthetischen und eines xenogenen Knochenersatzmaterials zur Sinusbodenaugmentation bei ehemaligen Tumorpatienten
Influence of metasomatism on vanadium-based redox proxies for mantle peridotite
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
Myeloproliferative disorders : current perspectives on diagnostic criteria, histopathology and treatment in essential thrombocythemia, polycythemia rubra vera and chronic idiopathic myelofibrosis
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option
Differentialdiagnostik der frühen primären Myelofibrose (präPMF) gemäß der neuen WHO-Klassifikation
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms : document summary and in-depth discussion
A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies
Epstein-Barr virus–specific cytokine-induced killer cells for treatment of Epstein-Barr virus–related malignant lymphoma
Vemurafenib in Langerhans cell histiocytosis : report of a pediatric patient and review of the literature
Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors
Histologische, histomorphometrische und klinische Vergleichsanalyse eines synthetischen und eines xenogenen Knochenersatzmaterials zur Sinusbodenaugmentation bei ehemaligen Tumorpatienten
Influence of metasomatism on vanadium-based redox proxies for mantle peridotite
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
Myeloproliferative disorders : current perspectives on diagnostic criteria, histopathology and treatment in essential thrombocythemia, polycythemia rubra vera and chronic idiopathic myelofibrosis
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option